Cohen Klingenstein LLC Eli Lilly & CO Transaction History

Cohen Klingenstein LLC

$2.76 Billion
Q3 2024

A detailed history of Cohen Klingenstein LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cohen Klingenstein LLC holds 138,464 shares of LLY stock, worth $110 Million. This represents 4.45% of its overall portfolio holdings.

Number of Shares

138,464

Previous 138,464 -0.0%

Holding current value

$110 Million

Previous $125 Million 2.15%

% of portfolio

4.45%

Previous 4.73%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$724.87 - $909.04 $1.3 Million - $1.63 Million	-1,798 Reduced 1.28%	138,464 $125 Million
Q1 2024 Apr 12, 2024	SELL	$592.2 - $792.28 $41,454 - $55,459	-70 Reduced 0.05%	140,262 $109 Million
Q4 2023 Jan 12, 2024	SELL	$525.19 - $619.13 $1.17 Million - $1.38 Million	-2,234 Reduced 1.57%	140,332 $81.8 Million
Q2 2023 Jul 14, 2023	SELL	$350.74 - $468.98 $104,871 - $140,225	-299 Reduced 0.21%	142,566 $66.9 Million
Q4 2022 Jan 13, 2023	SELL	$321.55 - $374.67 $815,129 - $949,788	-2,535 Reduced 1.74%	142,865 $0
Q4 2021 Jan 14, 2022	SELL	$224.85 - $279.04 $11.2 Million - $14 Million	-50,000 Reduced 25.59%	145,400 $40.2 Million
Q3 2021 Oct 15, 2021	SELL	$221.6 - $272.71 $1.4 Million - $1.72 Million	-6,300 Reduced 3.12%	195,400 $45.1 Million
Q3 2020 Oct 19, 2020	SELL	$146.22 - $169.13 $131,598 - $152,217	-900 Reduced 0.44%	201,700 $29.9 Million
Q3 2019 Oct 17, 2019	BUY	$106.79 - $116.16 $1.07 Million - $1.16 Million	10,000 Added 5.19%	202,600 $22.7 Million
Q2 2019 Jul 15, 2019	SELL	$110.79 - $129.32 $1.11 Million - $1.29 Million	-10,000 Reduced 4.94%	192,600 $21.3 Million
Q1 2019 Apr 16, 2019	BUY	$111.31 - $131.02 $12 Million - $14.2 Million	108,000 Added 114.16%	202,600 $26.3 Million
Q3 2017 Oct 17, 2017	BUY	$77.07 - $85.54 $7.29 Million - $8.09 Million	94,600	94,600 $8.09 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cohen Klingenstein LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cohen Klingenstein LLC with notifications on news.

Account

Cohen Klingenstein LLC Eli Lilly & CO Transaction History